These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 26632010)

  • 1. My approach to the use of aspirin.
    Dalen JE
    Trends Cardiovasc Med; 2016 Feb; 26(2):207. PubMed ID: 26632010
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular pharmacology core reviews: aspirin.
    Gaglia MA; Clavijo L
    J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):505-13. PubMed ID: 24057863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.
    Kolber MR; Korownyk C
    Expert Opin Pharmacother; 2014 Feb; 15(2):153-7. PubMed ID: 24206142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin in primary and secondary prevention in elderly adults revisited.
    Wilson R; Gazzala J; House J
    South Med J; 2012 Feb; 105(2):82-6. PubMed ID: 22267096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin resistance in the era of personalized medicine: Should we not take it personally?
    Naimo PS; McGiffin D; Konstantinov IE
    J Thorac Cardiovasc Surg; 2015 Dec; 150(6):e99-100. PubMed ID: 26463652
    [No Abstract]   [Full Text] [Related]  

  • 6. Who can resist aspirin?
    Smith PS
    Nursing; 2005 Feb; 35(2):20. PubMed ID: 15706257
    [No Abstract]   [Full Text] [Related]  

  • 7. Laboratory detection of 'aspirin resistance': what test should we use (if any)?
    Cattaneo M
    Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin resistance: current concepts.
    Mason PJ; Freedman JE; Jacobs AK
    Rev Cardiovasc Med; 2004; 5(3):156-63. PubMed ID: 15346099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteric-coated aspirin: review shows similar inhibition of platelet aggregation to ordinary dispersible aspirin.
    Cardiovasc J S Afr; 2007; 18(1):41, 43. PubMed ID: 17392997
    [No Abstract]   [Full Text] [Related]  

  • 10. Controversies in antiplatelet therapy for patients with cardiovascular disease.
    Bates ER; Lau WC
    Circulation; 2005 May; 111(17):e267-71. PubMed ID: 15867186
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet function assessed by whole-blood aggregometry in patients undergoing non-cardiac surgery.
    Oscarsson A; Öster S; Fredrikson M; Lindahl TL; Eintrei C
    Eur J Anaesthesiol; 2011 May; 28(5):363-9. PubMed ID: 21499200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards a definition of aspirin resistance: a typological approach.
    Weber AA; Przytulski B; Schanz A; Hohlfeld T; Schrör K
    Platelets; 2002 Feb; 13(1):37-40. PubMed ID: 11918835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of aspirin in cardiovascular prevention: implications of aspirin resistance.
    Gasparyan AY; Watson T; Lip GY
    J Am Coll Cardiol; 2008 May; 51(19):1829-43. PubMed ID: 18466797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acetylsalicylic acid resistance--clinical diagnosis with unclear mechanism].
    Hillarp A
    Lakartidningen; 2004 Nov; 101(45):3504-6, 3508-9. PubMed ID: 15575422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies show aspirin affects women differently than men.
    Heart Advis; 2006 Oct; 9(10):7. PubMed ID: 17219643
    [No Abstract]   [Full Text] [Related]  

  • 16. Secondary prevention of cardiovascular disease with vorapaxar: a new era of 3-drug antiplatelet therapy?
    Krantz MJ; Kaul S
    JAMA Intern Med; 2015 Jan; 175(1):9-10. PubMed ID: 25365757
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug delivery and therapeutic impact of extended-release acetylsalicylic acid.
    Bliden KP; Patrick J; Pennell AT; Tantry US; Gurbel PA
    Future Cardiol; 2016 Jan; 12(1):45-58. PubMed ID: 26356085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aspirin resistance candidate genes and their association with the risk of fatal cardiovascular events].
    Grinshtein YI; Kosinova AA; Grinshtein IY
    Ter Arkh; 2013; 85(5):95-100. PubMed ID: 23819347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A brief review on high on-aspirin residual platelet reactivity.
    Pettersen AA; Arnesen H; Seljeflot I
    Vascul Pharmacol; 2015; 67-69():6-9. PubMed ID: 25869498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin resistance.
    Tran HA; Anand SS; Hankey GJ; Eikelboom JW
    Thromb Res; 2007; 120(3):337-46. PubMed ID: 17241655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.